May 2015 Briefing – OBGYN & Women’s Health
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women's Health for May 2015. This roundup...
ASCO: Greater Breast Tissue Removal Reduces Further Surgery
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer
ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
ASCO: MMR Deficiency Predicts Pembrolizumab Response
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
Weight-Based Enoxoparin Dosing Best for Obese After C-Section
Weight-based dosing more effective than BMI-based dosing for venous thromboembolism prophylaxis
AMD Predicts Poorer Survival in Older Women
In women older than 80 years, early AMD linked to all-cause and non-CVD, non-cancer mortality
Insulin Resistance Not Linked to Post-Adolescent Acne
No differences in fasting blood glucose, fasting insulin, HOMA-IR index for post-teen acne, controls
Outpatient Uterine Polypectomy More Cost-Effective
Slightly less effective than inpatient treatment, but outpatient treatment is less expensive
Fruit, Vegetable Intake Linked to Hip Fracture
Dose-response association noted with increased fracture rates for intake below five servings/day
AMA: Physicians Driving the Slowing of Health Care Costs
Physicians' spending grew more slowly over 2003 to 2013 than hospital and clinical spending
